Although further study is needed to confirm the beneficial effect of PGC-1α activator on immunological reactions and to determine the molecules involved in the pathway, this approach might be applicable to a broad array of allergic diseases including allergic rhinitis and atopic dermatitis in addition to bronchial asthma. Here, PPARGC1A is linked to allergic disease.